Courau, Tristan https://orcid.org/0000-0003-1819-9516
Jaszczak, Rebecca G.
Samad, Bushra https://orcid.org/0000-0002-2893-0897
Flynn, Emily
Chew, Nayvin W.
Reeder, Gabriella C.
Tsui, Jessica
Teklu, Semhar
Pass, Lomax F.
Edwards, Austin W.
Naser, Mohammad
Ray, Arja
Wismer, Harrison
Bunis, Daniel
Lupin-Jimenez, Leonard
Gavil, Noah V.
Masopust, David https://orcid.org/0000-0002-9440-3884
Graham, John P.
Skelly, Daniel A. https://orcid.org/0000-0002-2329-2216
Vesco, Xavier https://orcid.org/0009-0008-0279-5923
Liu, Edison T. https://orcid.org/0000-0003-4293-4795
Fragiadakis, Gabriela K. https://orcid.org/0000-0001-9703-2591
Combes, Alexis J. https://orcid.org/0000-0002-9110-6542
Krummel, Matthew F. https://orcid.org/0000-0001-7915-3533
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA197363)
AbbVie
Amgen
Bristol-Myers Squibb
Genentech
Pfizer
The UCSF ImmunoX HuMu CoProject funding (internal to UCSF) was obtained by MFK.
Article History
Received: 30 July 2025
Accepted: 18 March 2026
First Online: 19 May 2026
Competing interests
: The authors declare no competing interests.